...
首页> 外文期刊>Kidney international. >Cellular and molecular aspects of drug transport in the kidney
【24h】

Cellular and molecular aspects of drug transport in the kidney

机译:肾脏中药物转运的细胞和分子方面

获取原文
           

摘要

Cellular and molecular aspects of drug transport in the kidney. The kidney plays an important role in the elimination of numerous hydrophilic xenobiotics, including drugs, toxins, and endogenous compounds. It has developed high-capacity transport systems to prevent urinary loss of filtered nutrients, as well as electrolytes, and simultaneously to facilitate tubular secretion of a wide range of organic ions. Transport systems for organic anions and cations are primarily involved in the secretion of drugs in renal tubules. The identification and characterization of organic anion and cation transporters have been progressing at the molecular level. To date, many members of the organic anion transporter (OAT), organic cation transporter (OCT), and organic anion-transporting polypeptide (oatp) gene families have been found to mediate the transport of diverse organic anions and cations. It has also been suggested that ATP-dependent primary active transporters such as MDR1/P-glycoprotein and the multidrug resistance-associated protein (MRP) gene family function as efflux pumps of renal tubular cells for more hydrophobic molecules and anionic conjugates. Tubular reabsorption of peptide-like drugs such as -lactam antibiotics across the brush-border membranes appears to be mediated by two distinct H+/peptide cotransporters: PEPT1 and PEPT2. Renal disposition of drugs is the consequence of interaction and/or transport via these diverse secretory and absorptive transporters in renal tubules. Studies of the functional characteristics, such as substrate specificity and transport mechanisms, and of the localization of cloned drug transporters could provide information regarding the cellular network involved in renal handling of drugs. Detailed information concerning molecular and cellular aspects of drug transporters expressed in the kidney has facilitated studies of the mechanisms underlying renal disposition as well as transporter-mediated drug interactions.
机译:肾脏中药物运输的细胞和分子方面。肾脏在消除众多亲水性异质生物(包括药物,毒素和内源性化合物)中起着重要作用。它已开发出高容量的运输系统,以防止尿液过滤后的营养物以及电解质流失,并同时促进各种有机离子的管状分泌。有机阴离子和阳离子的转运系统主要参与肾小管中药物的分泌。有机阴离子和阳离子转运蛋白的鉴定和表征已在分子水平上发展。迄今为止,已经发现有机阴离子转运蛋白(OAT),有机阳离子转运蛋白(OCT)和有机阴离子转运多肽(oatp)基因家族的许多成员介导了各种有机阴离子和阳离子的转运。还已经提出,ATP依赖性主要活性转运蛋白(例如MDR1 / P-糖蛋白)和多药耐药相关蛋白(MRP)基因家族起着肾小管细胞外排泵作用,以吸收更多的疏水性分子和阴离子结合物。肽样药物(例如-内酰胺类抗生素)在刷状边界膜上的管状重吸收似乎是由两种不同的H + /肽共转运蛋白:PEPT1和PEPT2介导的。肾脏的药物处置是通过肾小管中这些不同的分泌性和吸收性转运蛋白相互作用和/或转运的结果。对功能特性(例如底物特异性和转运机制)以及克隆的药物转运蛋白的定位的研究可以提供有关参与肾脏肾脏处理药物的细胞网络的信息。有关在肾脏中表达的药物转运蛋白的分子和细胞方面的详细信息,有助于研究肾脏处置以及转运蛋白介导的药物相互作用的基本机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号